Pratesi G - Search Results

1

BBR 3464: a novel triplatinum complex, exhibiting a preclinical profile of antitumor efficacy different from cisplatin.

Manzotti C, Pratesi G, Menta E, Di Domenico R, Cavalletti E, Fiebig HH, Kelland LR, Farrell N, Polizzi D, Supino R, Pezzoni G, Zunino F. Manzotti C, et al. Among authors: pratesi g. Clin Cancer Res. 2000 Jul;6(7):2626-34. Clin Cancer Res. 2000. PMID: 10914703

2

Efficacy of the novel camptothecin gimatecan against orthotopic and metastatic human tumor xenograft models.

De Cesare M, Pratesi G, Veneroni S, Bergottini R, Zunino F. De Cesare M, et al. Among authors: pratesi g. Clin Cancer Res. 2004 Nov 1;10(21):7357-64. doi: 10.1158/1078-0432.CCR-04-0962. Clin Cancer Res. 2004. PMID: 15534112

3

Apoptosis as a determinant of tumor sensitivity to topotecan in human ovarian tumors: preclinical in vitro/in vivo studies.

Caserini C, Pratesi G, Tortoreto M, Bedogné B, Carenini N, Supino R, Perego P, Righetti SC, Zunino F. Caserini C, et al. Among authors: pratesi g. Clin Cancer Res. 1997 Jun;3(6):955-61. Clin Cancer Res. 1997. PMID: 9815771

4

Improved efficacy and enlarged spectrum of activity of a novel anthracycline disaccharide analogue of doxorubicin against human tumor xenografts.

Pratesi G, De Cesare M, Caserini C, Perego P, Dal Bo L, Polizzi D, Supino R, Bigioni M, Manzini S, Iafrate E, Salvatore C, Casazza A, Arcamone F, Zunino F. Pratesi G, et al. Clin Cancer Res. 1998 Nov;4(11):2833-9. Clin Cancer Res. 1998. PMID: 9829750

5

A novel taxane with improved tolerability and therapeutic activity in a panel of human tumor xenografts.

Polizzi D, Pratesi G, Tortoreto M, Supino R, Riva A, Bombardelli E, Zunino F. Polizzi D, et al. Among authors: pratesi g. Cancer Res. 1999 Mar 1;59(5):1036-40. Cancer Res. 1999. PMID: 10070960

6

A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenografts.

Pratesi G, Perego P, Polizzi D, Righetti SC, Supino R, Caserini C, Manzotti C, Giuliani FC, Pezzoni G, Tognella S, Spinelli S, Farrell N, Zunino F. Pratesi G, et al. Br J Cancer. 1999 Aug;80(12):1912-9. doi: 10.1038/sj.bjc.6690620. Br J Cancer. 1999. PMID: 10471039 Free PMC article.

7

Oral efficacy and bioavailability of a novel taxane.

Polizzi D, Pratesi G, Monestiroli S, Tortoreto M, Zunino F, Bombardelli E, Riva A, Morazzoni P, Colombo T, D'Incalci M, Zucchetti M. Polizzi D, et al. Among authors: pratesi g. Clin Cancer Res. 2000 May;6(5):2070-4. Clin Cancer Res. 2000. PMID: 10815934

8

Cellular bases of the antitumor activity of the novel taxane IDN 5109 (BAY59-8862) on hormone-refractory prostate cancer.

Cassinelli G, Lanzi C, Supino R, Pratesi G, Zuco V, Laccabue D, Cuccuru G, Bombardelli E, Zunino F. Cassinelli G, et al. Among authors: pratesi g. Clin Cancer Res. 2002 Aug;8(8):2647-54. Clin Cancer Res. 2002. PMID: 12171897

9

Pattern of antitumor activity of a novel camptothecin, ST1481, in a large panel of human tumor xenografts.

Pratesi G, De Cesare M, Carenini N, Perego P, Righetti SC, Cucco C, Merlini L, Pisano C, Penco S, Carminati P, Vesci L, Zunino F. Pratesi G, et al. Clin Cancer Res. 2002 Dec;8(12):3904-9. Clin Cancer Res. 2002. PMID: 12473606

10

Antiangiogenic effects of the novel camptothecin ST1481 (gimatecan) in human tumor xenografts.

Petrangolini G, Pratesi G, De Cesare M, Supino R, Pisano C, Marcellini M, Giordano V, Laccabue D, Lanzi C, Zunino F. Petrangolini G, et al. Among authors: pratesi g. Mol Cancer Res. 2003 Oct;1(12):863-70. Mol Cancer Res. 2003. PMID: 14573787

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

384 results

Search Page

Filters